- Home
- CRIS vs HUIZ Comparison
CRIS vs HUIZ Comparison
Compare CRIS & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- HUIZ
- Stock Information
- Founded
- CRIS 2000
- HUIZ 2006
- Country
- CRIS United States
- HUIZ China
- Employees
- CRIS N/A
- HUIZ N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- HUIZ Specialty Insurers
- Sector
- CRIS Health Care
- HUIZ Finance
- Exchange
- CRIS Nasdaq
- HUIZ Nasdaq
- Market Cap
- CRIS 27.5M
- HUIZ 32.0M
- IPO Year
- CRIS 2000
- HUIZ 2020
- Fundamental
- Price
- CRIS $3.87
- HUIZ $3.35
- Analyst Decision
- CRIS Strong Buy
- HUIZ
- Analyst Count
- CRIS 3
- HUIZ 0
- Target Price
- CRIS $23.00
- HUIZ N/A
- AVG Volume (30 Days)
- CRIS 238.7K
- HUIZ 329.2K
- Earning Date
- CRIS 02-06-2025
- HUIZ 12-10-2024
- Dividend Yield
- CRIS N/A
- HUIZ N/A
- EPS Growth
- CRIS N/A
- HUIZ N/A
- EPS
- CRIS N/A
- HUIZ 0.29
- Revenue
- CRIS $10,259,000.00
- HUIZ $170,927,079.00
- Revenue This Year
- CRIS N/A
- HUIZ N/A
- Revenue Next Year
- CRIS N/A
- HUIZ $10.46
- P/E Ratio
- CRIS N/A
- HUIZ $11.65
- Revenue Growth
- CRIS 0.44
- HUIZ N/A
- 52 Week Low
- CRIS $2.86
- HUIZ $0.43
- 52 Week High
- CRIS $17.49
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- CRIS 53.89
- HUIZ 58.77
- Support Level
- CRIS $2.86
- HUIZ $3.06
- Resistance Level
- CRIS $4.50
- HUIZ $3.56
- Average True Range (ATR)
- CRIS 0.39
- HUIZ 0.46
- MACD
- CRIS 0.09
- HUIZ -0.06
- Stochastic Oscillator
- CRIS 61.59
- HUIZ 53.57
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.